FDA Did Not Seek Plan B “Minority Opinion,” Crawford Tells Subcommittee
This article was originally published in The Tan Sheet
Executive Summary
FDA never asked for or received a memo from former Reproductive Health Drugs Advisory Committee member David Hager, MD, outlining a "minority opinion" on the possible Rx-to-OTC switch of Plan B, Commissioner Lester Crawford stated July 26